yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q36712865-275FE01F-A920-4B72-B297-C4E674E02896
Q36712865-275FE01F-A920-4B72-B297-C4E674E02896
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36712865-275FE01F-A920-4B72-B297-C4E674E02896
Reduced risk of hypoglycemia with once-daily glargine versus twice-daily NPH and number needed to harm with NPH to demonstrate the risk of one additional hypoglycemic event in type 2 diabetes: Evidence from a long-term controlled trial.
P2860
Q36712865-275FE01F-A920-4B72-B297-C4E674E02896
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36712865-275FE01F-A920-4B72-B297-C4E674E02896
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4e57afb3c960ea790307cd5e0defcf8599b79bc7
P2860
A one-year, randomised, multicentre trial comparing insulin glargine with NPH insulin in combination with oral agents in patients with type 2 diabetes.